Combination therapy of chitosan, gynostemma, and motherwort alleviates the progression of experimental rat chronic renal failure by inhibiting STAT1 activation.

Bai, Wenxia; Wang, Shudong; An, Shanshan; Guo, Mengjie; Gong, Guangming; Liu, Wenya; Ma, Shaoxin; Li, Xin; Fu, Jihua; Yao, Wenbing

Bai, Wenxia; Wang, Shudong; An, Shanshan; Guo, Mengjie; Gong, Guangming; Liu, Wenya; Ma, Shaoxin; Li, Xin; Fu, Jihua; Yao, Wenbing.

Afiliación

Bai W; Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
Wang S; Department of Pharmaceutics, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
An S; Department of Physiology, China Pharmaceutical University, Nanjing, China.
Guo M; School of Medicine and Life Sciences, Nanjing University of Traditional Chinese Medicine, Nanjing, China.
Gong G; Department of Pharmaceutics, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Liu W; Department of Pharmaceutics, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Ma S; Department of Physiology, China Pharmaceutical University, Nanjing, China.
Li X; Department of Physiology, China Pharmaceutical University, Nanjing, China.
Fu J; Department of Physiology, China Pharmaceutical University, Nanjing, China.
Yao W; Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.

Oncotarget ; 9(21): 15498-15511, 2018 Mar 20.

Article en En | MEDLINE | ID: mdl-29643988

Palabras clave

STAT1; chronic renal failure

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google